CRISPR Therapeutics

ISIN CH0334081137

 | 

WKN A2AT0Z

Market cap (in EUR)
4,576 m
Country
Switzerland
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.
Show more Show less
Healthcare Biopharmaceuticals Other Biopharmaceuticals Switzerland

Financials

Key metrics

Market capitalisation, EUR 4,576 m
EPS, EUR -5.05
P/B ratio 2.7
P/E ratio -
Dividend yield 0.00%

Income statement (2024)

Revenue, EUR 34 m
Net income, EUR -339 m
Profit margin -981.54%

What ETF is CRISPR Therapeutics in?

There are 7 ETFs which contain CRISPR Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of CRISPR Therapeutics is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Weight Investment focus Fund size (in m EUR)
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Distributing 0.01%
Equity
World
Multi-Factor Strategy
139
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0.48%
Equity
United States
Health Care
Biotech
44
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating 0.01%
Equity
World
Multi-Factor Strategy
755
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.01%
Equity
World
Social/Environmental
483
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.01%
Equity
North America
Social/Environmental
27
L&G Russell 2000 US Small Cap Quality UCITS ETF 0.21%
Equity
United States
Small Cap
172
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.09%
Equity
United States
Small Cap
176
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.